Table 3.
Unadjusted Incidence Rates of End-Stage Renal Disease Among HIV-Infected Patients in Care
| Characteristic | Incidence Rate per 100 000 PY (95% CI) |
|
|---|---|---|
| Overall (N = 286) | Well-Suppresseda (n = 22) | |
| Overall | 179 (160–201) | 68 (45–104) |
| Sex | ||
| Male | 157 (136–180) | 56 (34–93) |
| Female | 259 (211–320) | 127 (61–269) |
| Race | ||
| White | 45 (32–64) | 13 (3–51) |
| Black | 437 (384–498) | 204 (121–345) |
| Ethnicity | ||
| Hispanic | 80 (49–130) | 65 (21–202) |
| Risk behavior | ||
| IDU | 263 (202–343) | 161 (60–428) |
| Non-IDU | 166 (146–189) | 61 (38–96) |
| Age, y | ||
| 18–39 | 142 (114–177) | 45 (17–120) |
| 40–49 | 172 (143–206) | 52 (25–109) |
| 50–59 | 234 (185–295) | 83 (37–184) |
| ≥60 | 285 (190–429) | 195 (81–469) |
| eGFR category, mL/min | ||
| ≥90 | 73 (57–93) | 11 (3–42) |
| 60–89 | 233 (176–308) | 51 (17–159) |
| 45–59 | 1875 (1340–2625) | 772 (290–2056) |
| 30–44 | 4778 (3396–6720) | 2008 (647–6225) |
| 15–29 | 14 674 (10 197–21 117) | 3193 (449–22 668) |
Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; HIV, human immunodeficiency virus; IDU, injection drug use; PY, person-years [26].
a Defined as HIV RNA ≤400 copies/mL for 90% of the observed follow-up time.